The Latest “Buzz on the Street” Show: Featuring Pasha Brands (CSE: CRFT) (OTC: CRFTF) North 40 Cannabis Agreement

Published on: 13 Aug, 2019


FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Pasha Brands Secures Supply Agreement with Canada’s First Licensed Micro Processor, North 40 Cannabis.”

Pasha Brands Ltd. (CSE: CRFT) (OTC: CRFTF) (FSE: ZZD), North America’s largest craft cannabis brand house, is pleased to announce that its wholly owned subsidiary, BC Craft Supply Co. Ltd (“BC Craft”), has signed a supply agreement with Canada’s first licensed micro processor, North 40 Cannabis.

Based in Vancouver, British Columbia, Pasha Brands is a vertically integrated organization that is firmly rooted in BC’s craft cannabis industry, which boasts an international reputation. With proven capabilities in cannabis cultivation, genetic research and development, product, processing, and retail, Pasha is uniquely positioned in the new legal cannabis market through its network of hundreds of craft cannabis suppliers under the Pasha umbrella.

Pasha’s subsidiary, BC Craft Supply Co. Ltd., is developing a craft cannabis campus, which is dedicated to bringing craft quality into the newly legal cannabis market in Canada. BC Craft Supply Co. Ltd. is driven to assist craft growers in obtaining security clearance and licensing to grow as micro-cultivators, specializing in education and compliance to bring growers into the regulated cannabis supply market.

As the cannabis industry continues to evolve, researchers are constantly uncovering new aspects of the plants. For instance, a study by the University of Colorado suggested that cannabis can be used to increase the survivability of a heart attack. The study collected over 1.2 million medical records of acute myocardial infarctions (AMI) and among those records, it was discovered that 3,854 of those patients were cannabis consumers. While it would be likely assumed that they would have more adverse conditions than non-consumers, it was the exact opposite, as the researchers noted that the cannabis consumers had a decreased risk of death, shock, or need to insert a balloon into a blocked artery. The researchers mentioned that they do not exactly understand the scientific reasoning behind increased survivability. However, they speculated that the activation of CB2 receptors found in the endocannabinoid system can provide therapeutic cardioprotective effects. The researchers then pointed to another study that suggested cannabis could increase blood flow, preventing blood clots and strokes. Furthermore, a multitude of studies have also concluded that cannabis can be effectively used to treat other medical conditions such as symptoms associated with cancer, chronic pain, epilepsy, and multiple sclerosis. Medical cannabis is predominantly used among patients suffering from chronic pain because the activation of the CB2 receptors can help alleviate the pain as well as reduce inflammation. Moreover, thousands of medical institutions and researchers are conducting trials to better understand the psychological and neurological effects of cannabis. And while the industry remains within its infancy stage, it is rapidly accelerating. In the near future, cannabis could potentially become a globally available medicinal treatment for a variety of conditions. As a result, the global legal marijuana market is expected to reach USD 146.4 Billion by 2025 while registering a CAGR of 34.6%, according to data compiled by Grand View Research.

Medical cannabis is already prevalent in many regions across the world such as parts of the U.S., Australia, Canada, France, Germany, Thailand, and South Korea. However, due to the lack of research and the plant’s potential for abuse, government regulators have explicitly outlined the requirements patients must meet in order to be eligible for medical use. Germany’s parliament allows patients to use medical cannabis for multiple sclerosis and chronic pain, but it heavily depends on the severity of their condition. On the other hand, South Korea only allows the use of medical cannabis for epilepsy, symptoms of HIV/AIDS, and cancer-related treatments. While Germany and South Korea recently adopted medical cannabis, the U.S. and Canada have had medical cannabis use for quite some time. The U.S. began adopting medical cannabis back in the 1990s when California became the first state to legalize medical use. Canada legalized medical cannabis use back in 2001, but only allowed it for two uses. Since then, both markets have drastically changed and additionally, both have implemented a recreational market. Largely, the U.S. and Canada dominate cannabis market because of their early adoption. However, the major challenge for companies is keeping up with trends. For instance, when legalization first began, dried cannabis flower was widely popular. Now ,however, oils are in high demand. Moreover, consumer preferences have changed and consumers are beginning to demand more premium and higher quality products. Specifically, in the U.S. and Canada, “craft cannabis” has become an emerging product that is quickly gaining popularity. Cultivators engaging in craft cannabis carefully nurture each individual plant to ensure its high quality and potency. Notably, craft cultivators also grow their cannabis organically, meaning they avoid the use of artificial products that may damage the strain and cannabinoid content. Overall, the meticulous care and distinct growing techniques create an eccentric strain that stands out from traditional products. “More and more consumers desire a tangible connection with the cannabis flower and care about small farm values such as sustainability, craftsmanship, organic principles and hands-on cultivation techniques,” said Rose Mattio, Founder of Rosie Mattio Public Relations.

For more information, please visit: Pasha Brands Ltd.

For more corporate news on Pasha Brands Ltd., check out the Buzz on the Street

About Buzz on the Street: One of FinancialBuzz.com’s latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street is 100% original content, brought to you by Financial Buzz Media.

Ratings

Ratings
  • 314Views
  • 0Comments

Recommend to Friends

  • facebook
  • Twitter
  • google plus
  • pinterest
  • Digg
  • stumbleupon
  • Reddit
  • linkedin

Nikita Medvedev

Email: Nikita@financialinsiders.com

@Newsletter

Sign Up for Weekly Updates

Opt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!

Related Posts

05 Jul, 2017 1144
10 Jul, 2017 1143
12 Jul, 2017 1100
18 Jul, 2017 1036

Comments

There is no comment on this article